Risk of neurological adverse events during tumour necrosis factor inhibitor treatment for arthritis: A population-based cohort study from DANBIO and the Danish National Patient Registry

Tine I. Kopp; Rikke K. Jacobsen; Melinda Magyari; Else H. Ibfelt; Henning Locht; Finn T. Sellebjerg; Dorte Vendelbo; Rene Cordtz; Lene Dreyer

doi:10.1002/pds.4629

Risk of neurological adverse events during tumour necrosis factor inhibitor treatment for arthritis: A population-based cohort study from DANBIO and the Danish National Patient Registry

Tine I. Kopp, Rikke K. Jacobsen, Melinda Magyari, Else H. Ibfelt, Henning Locht, Finn T. Sellebjerg, Dorte Vendelbo, Rene Cordtz, Lene Dreyer

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	313
Journal	Pharmacoepidemiology and Drug Safety
Volume	27
Issue number	Suppl. 2
Pages (from-to)	145
Number of pages	1
ISSN	1053-8569
DOIs	https://doi.org/10.1002/pds.4629
Publication status	Published - 1 Aug 2018
Event	34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management - Prag, Czech Republic Duration: 22 Aug 2018 → 26 Aug 2018 Conference number: 34 http://www.pharmacoepi.org/meetings/34icpe/

Conference

Conference	34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Number	34
Country/Territory	Czech Republic
City	Prag
Period	22/08/2018 → 26/08/2018
Internet address	http://www.pharmacoepi.org/meetings/34icpe/

Bibliographical note

Abstract no. 313

Access to Document

10.1002/pds.4629

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Kopp, T. I., Jacobsen, R. K., Magyari, M., Ibfelt, E. H., Locht, H., Sellebjerg, F. T., Vendelbo, D., Cordtz, R., & Dreyer, L. (2018). Risk of neurological adverse events during tumour necrosis factor inhibitor treatment for arthritis: A population-based cohort study from DANBIO and the Danish National Patient Registry. Pharmacoepidemiology and Drug Safety, 27(Suppl. 2), 145. Article 313. https://doi.org/10.1002/pds.4629

@article{86422922f6a649e5972186aac76fb407,

title = "Risk of neurological adverse events during tumour necrosis factor inhibitor treatment for arthritis: A population-based cohort study from DANBIO and the Danish National Patient Registry",

author = "Kopp, {Tine I.} and Jacobsen, {Rikke K.} and Melinda Magyari and Ibfelt, {Else H.} and Henning Locht and Sellebjerg, {Finn T.} and Dorte Vendelbo and Rene Cordtz and Lene Dreyer",

note = "Abstract no. 313; 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management ; Conference date: 22-08-2018 Through 26-08-2018",

year = "2018",

month = aug,

day = "1",

doi = "10.1002/pds.4629",

language = "English",

volume = "27",

pages = "145",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "Wiley",

number = "Suppl. 2",

url = "http://www.pharmacoepi.org/meetings/34icpe/",

}

Kopp, TI, Jacobsen, RK, Magyari, M, Ibfelt, EH, Locht, H, Sellebjerg, FT, Vendelbo, D, Cordtz, R & Dreyer, L 2018, 'Risk of neurological adverse events during tumour necrosis factor inhibitor treatment for arthritis: A population-based cohort study from DANBIO and the Danish National Patient Registry', Pharmacoepidemiology and Drug Safety, vol. 27, no. Suppl. 2, 313, pp. 145. https://doi.org/10.1002/pds.4629

Risk of neurological adverse events during tumour necrosis factor inhibitor treatment for arthritis: A population-based cohort study from DANBIO and the Danish National Patient Registry. / Kopp, Tine I.; Jacobsen, Rikke K.; Magyari, Melinda et al.
In: Pharmacoepidemiology and Drug Safety, Vol. 27, No. Suppl. 2, 313, 01.08.2018, p. 145.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Risk of neurological adverse events during tumour necrosis factor inhibitor treatment for arthritis

T2 - 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management

AU - Kopp, Tine I.

AU - Jacobsen, Rikke K.

AU - Magyari, Melinda

AU - Ibfelt, Else H.

AU - Locht, Henning

AU - Sellebjerg, Finn T.

AU - Vendelbo, Dorte

AU - Cordtz, Rene

AU - Dreyer, Lene

N1 - Conference code: 34

PY - 2018/8/1

Y1 - 2018/8/1

U2 - 10.1002/pds.4629

DO - 10.1002/pds.4629

M3 - Conference abstract in journal

SN - 1053-8569

VL - 27

SP - 145

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - Suppl. 2

M1 - 313

Y2 - 22 August 2018 through 26 August 2018

ER -